Prevention of vancomycin induced nephrotoxicity: a review of preclinical data Sepideh ElyasiHossein KhaliliSimin Dashti-Khavidaki Review Article 21 September 2012 Pages: 747 - 754
Citalopram and cardiac toxicity M. J. CookeW. S. Waring Review Article 21 September 2012 Pages: 755 - 760
Nurse-led interventions to enhance adherence to chronic medication: systematic review and meta-analysis of randomised controlled trials Yoleen P. Van CampBart Van RompaeyMonique M. Elseviers Review Article 09 October 2012 Pages: 761 - 770
Influence of CYP2C19 loss-of-function variants on the antiplatelet effects and cardiovascular events in clopidogrel-treated Chinese patients undergoing percutaneous coronary intervention Jian-Jun ZouHong-Guang XieGuang-Ji Wang Clinical Trial 22 September 2012 Pages: 771 - 777
Psychological and physiological effects of bupropion compared to methylphenidate after prolonged administration in healthy volunteers (NCT00285155) Hugues ChevassusAnne FarretPierre Petit Clinical Trial 09 October 2012 Pages: 779 - 787
CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation Paulo Caleb Junior Lima SantosCarla Luana DinardoAlexandre Costa Pereira Pharmacogenetics 19 September 2012 Pages: 789 - 797
CYP2C19 genotype has a major influence on labetalol pharmacokinetics in healthy male Chinese subjects Sze Wa ChanMiao HuBrian Tomlinson Pharmacogenetics 23 October 2012 Pages: 799 - 806
Effect of the P450 oxidoreductase *28 polymorphism on the pharmacokinetics of tacrolimus in Chinese healthy male volunteers Jing-Jing ZhangHua ZhangLi-Yan Miao Pharmacogenetics 25 October 2012 Pages: 807 - 812
Nilotinib population pharmacokinetics and exposure-response analysis in patients with imatinib-resistant or -intolerant chronic myeloid leukemia Francis J. GilesOphelia Q. P. YinHagop M. Kantarjian Pharmacokinetics and Disposition 05 October 2012 Pages: 813 - 823
A phase I study to assess the effect of food on the single dose bioavailability of the THC/CBD oromucosal spray C. G. StottL. WhiteG. W. Guy Pharmacokinetics and Disposition 04 October 2012 Pages: 825 - 834
The evaluation of potential pharmacokinetic interaction between sirolimus and tacrolimus in healthy volunteers Michael A. TortoriciVirginia ParksAlain Patat Pharmacokinetics and Disposition 04 October 2012 Pages: 835 - 842
Polymorphisms of UGT1A9 and UGT2B7 influence the pharmacokinetics of mycophenolic acid after a single oral dose in healthy Chinese volunteers Dong GuoLiang-Fang PangHong-Hao Zhou Pharmacokinetics and Disposition 10 October 2012 Pages: 843 - 849
Acetaminophen protein adduct formation following low-dose acetaminophen exposure: comparison of immediate-release vs extended-release formulations Laura P. JamesAngela ChiewDean Roberts Pharmacokinetics and Disposition 28 September 2012 Pages: 851 - 857
Population pharmacokinetics of bisoprolol in patients with chronic heart failure Valentina N. NikolicTatjana Jevtovic-StoimenovSlobodan M. Jankovic Pharmacokinetics and Disposition 24 October 2012 Pages: 859 - 865
Ticlopidine inhibits both O-demethylation and renal clearance of tramadol, increasing the exposure to it, but itraconazole has no marked effect on the ticlopidine-tramadol interaction Nora M. HagelbergTuukka SaarikoskiKlaus T. Olkkola Pharmacokinetics and Disposition 26 October 2012 Pages: 867 - 875
Effect of rifampicin on the pharmacokinetics and pharmacodynamics of ticagrelor in healthy subjects Renli TengPatrick MitchellKathleen Butler Pharmacokinetics and Disposition 24 October 2012 Pages: 877 - 883
Importance of cytochrome P450 (CYP450) in adverse drug reactions due to drug–drug interactions: a PharmacoVigilance study in France Anne Charlotte DantonFrançois MontastrucJean-Louis Montastruc Pharmacoepidemiology and Prescription 21 September 2012 Pages: 885 - 888
Drugs and Birth Defects: a knowledge database providing risk assessments based on national health registers Ulrika NörbyKarin KällénLars L. Gustafsson Pharmacoepidemiology and Prescription 26 September 2012 Pages: 889 - 899
Relationship between recommended chronic heart failure treatments and mortality over 8 years in real-world conditions: a pharmacoepidemiological study Patrick MaisonGaelle DesamericqIsabelle Macquin-Mavier Pharmacoepidemiology and Prescription 21 September 2012 Pages: 901 - 908
New prescriptions of spironolactone associated with angiotensin-converting-enzyme inhibitors and/or angiotensin receptor blockers and their laboratory monitoring from 2001 to 2008: a population study on older people living in the community in Italy Claudio BilottaCarlotta FranchiCarlo Vergani Pharmacoepidemiology and Prescription 21 September 2012 Pages: 909 - 917
Agreement among four drug information sources for the occurrence of warfarin drug interactions in Brazilian heart disease patients with a high prevalence of Trypanosoma cruzi infection Maria A. P. MartinsDaniel D. RibeiroAntonio L. P. Ribeiro Pharmacoepidemiology and Prescription 28 September 2012 Pages: 919 - 928
A population-based study comparing biosimilar versus originator erythropoiesis-stimulating agent consumption in 6,117 patients with renal anaemia Franziska HörbrandPeter BramlageReinhard Brunkhorst Pharmacoepidemiology and Prescription 02 October 2012 Pages: 929 - 936
Difficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage forms Julia T. SchieleRenate QuinzlerWalter E. Haefeli Pharmacoepidemiology and Prescription 29 September 2012 Pages: 937 - 948
The fuzzy line between needs, coverage, and excess in the Mexican Formulary List: an example of qualitative market width analysis Israel Rico-AlbaAlbert Figueras Pharmacoepidemiology and Prescription 23 October 2012 Pages: 949 - 956
Impact of regional copayment policy on selective serotonin reuptake inhibitor (SSRI) consumption and expenditure in Italy Gianfranco DamianiBruno FedericoWalter Ricciardi Pharmacoepidemiology and Prescription 23 October 2012 Pages: 957 - 963
Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and z-drugs consumption in nine European countries Emilie ClayBruno FalissardMondher Toumi Pharmacoepidemiology and Prescription Open access 01 November 2012 Pages: 1 - 10
Potentially inappropriate medications in a large cohort of patients in geriatric units: association with clinical and functional characteristics Martin F. FrommRenke MaasKarl-Günter Gaßmann Pharmacoepidemiology and Prescription 23 October 2012 Pages: 975 - 984
Parental reporting of adverse drug events and other drug-related problems in children in Finland L. Lindell-OsuagwuK. SepponenK. Vainio Pharmacoepidemiology and Prescription 24 October 2012 Pages: 985 - 994
Medication errors in the Middle East countries: A systematic review of the literature Zayed AlsulamiSharon ConroyImti Choonara Pharmacoepidemiology and Prescription Open access 23 October 2012 Pages: 995 - 1008
Orphan drugs, orphan diseases. The first decade of orphan drug legislation in the EU Roberta JoppiVittorio Bertele’Silvio Garattini Point of View 23 October 2012 Pages: 1009 - 1024
Discontinuation of anticoagulant care during admission to a psychiatric hospital H. Abdullah-KoolmeesT. GerbrandaE. R. Heerdink Short Communication 23 October 2012 Pages: 1025 - 1029
Wide intra- and inter-country variability in drug use and dosage in very-low-birth-weight newborns with severe infections Chiara PandolfiniFlorentia KaguelidouMaurizio Bonati Short Communication Open access 05 October 2012 Pages: 1031 - 1036
Dramatic improvement of myotonia permanens with flecainide: a two-case report of a possible bench-to-bedside pharmacogenetics strategy Jean-François DesaphyAnna ModoniDiana Conte Camerino Letter to the Editors Open access 03 October 2012 Pages: 1037 - 1039
Concomitant antibiotic usage does not augment the risk of inflammatory bowel disease with isotretinoin treatment for acne: a review of the Food and Drug Administration Adverse Event Reporting System Derrick J. StobaughParakkal DeepakEli D. Ehrenpreis Letter to the Editors 06 October 2012 Pages: 1041 - 1042
Influence of the VKORC1 3730 G > A polymorphism on warfarin dose Jane SkovElse-Marie BladbjergJørgen Jespersen Letter to the Editors 23 October 2012 Pages: 1043 - 1044
The influence of VKORC1 3730 G > A polymorphism on warfarin dose: reply Michela CiniCristina LegnaniGualtiero Palareti Letter to the Editors 12 October 2012 Pages: 1045 - 1045